A Miami resident is facing up to 20 years in prison after pleading guilty to fabricating results for a GlaxoSmithKline-funded study of asthma medication for pediatric patients.
Lisett Raventos, 46, of Miami, Florida, pleaded guilty today in the U.S. District Court for the Southern District of Florida today to one count of conspiracy to commit wire fraud. Raventos was the site director, the director of clinical operations, and a study coordinator at a medical clinic named Unlimited Medical Research (UM Research) in Miami, Florida. In pleading guilty, Raventos admitted that from approximately 2013 to 2016, she participated in a scheme to defraud an unnamed pharmaceutical company by fabricating the data and participation of subjects in a clinical trial at UM Research. The clinical trial was designed to investigate the safety and efficacy of an asthma medication in children between the ages of four and eleven. Raventos admitted that she falsified medical records to make it appear as though pediatric subjects made scheduled visits to UM Research, took study drugs as required, and received checks as payment.